Both WB findings on cell lines and IHC data from glioma xenograft specimens indicated that the expression of total β-catenin was decreased when CUX1 knockdown, and nuclear accumulation of active β-catenin were also relatively lower (Fig. 3b, c). This evidence concerns the gene CUX1 and central nervous system cancer.